X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (4598) 4598
humans (4416) 4416
tegafur - administration & dosage (3782) 3782
male (3150) 3150
female (2838) 2838
antineoplastic combined chemotherapy protocols - therapeutic use (2828) 2828
middle aged (2749) 2749
aged (2737) 2737
drug combinations (2683) 2683
oxonic acid - administration & dosage (1965) 1965
oncology (1611) 1611
adult (1604) 1604
stomach neoplasms - drug therapy (1502) 1502
uracil - administration & dosage (1250) 1250
tegafur - therapeutic use (1139) 1139
drug administration schedule (1063) 1063
chemotherapy (1062) 1062
cisplatin - administration & dosage (1049) 1049
stomach neoplasms - pathology (1026) 1026
administration, oral (959) 959
treatment outcome (884) 884
cancer (878) 878
tegafur - adverse effects (846) 846
s-1 (845) 845
antineoplastic combined chemotherapy protocols - adverse effects (765) 765
5-fluorouracil (763) 763
combined modality therapy (728) 728
oxonic acid - therapeutic use (726) 726
antineoplastic combined chemotherapy protocols - administration & dosage (721) 721
adenocarcinoma - drug therapy (717) 717
neoplasm staging (699) 699
aged, 80 and over (673) 673
fluorouracil - administration & dosage (673) 673
antimetabolites, antineoplastic - administration & dosage (669) 669
stomach neoplasms - surgery (652) 652
chemotherapy, adjuvant (588) 588
survival rate (579) 579
oxonic acid - adverse effects (557) 557
fluorouracil (543) 543
antimetabolites, antineoplastic - therapeutic use (477) 477
lymphatic metastasis (464) 464
cisplatin (461) 461
medicine & public health (461) 461
gastrectomy (455) 455
liver neoplasms - secondary (444) 444
carcinoma (430) 430
animals (425) 425
liver neoplasms - drug therapy (423) 423
leucovorin - administration & dosage (422) 422
disease-free survival (418) 418
deoxycytidine - analogs & derivatives (408) 408
pyridines - administration & dosage (406) 406
prognosis (405) 405
lung neoplasms - drug therapy (397) 397
gastric cancer (396) 396
surgery (389) 389
trial (383) 383
pharmacology & pharmacy (376) 376
colorectal neoplasms - drug therapy (374) 374
tegafur (365) 365
camptothecin - analogs & derivatives (361) 361
care and treatment (336) 336
camptothecin - administration & dosage (331) 331
retrospective studies (331) 331
deoxycytidine - administration & dosage (328) 328
remission induction (322) 322
stomach cancer (320) 320
fluorouracil - analogs & derivatives (318) 318
stomach neoplasms - mortality (314) 314
antineoplastic agents - administration & dosage (313) 313
uft (302) 302
therapy (300) 300
leucovorin (293) 293
capecitabine (286) 286
adenocarcinoma - pathology (283) 283
adenocarcinoma - secondary (283) 283
mice (276) 276
colorectal cancer (273) 273
cancer research (270) 270
follow-up studies (267) 267
research (266) 266
adjuvant chemotherapy (264) 264
tomography, x-ray computed (264) 264
uracil - therapeutic use (262) 262
antimetabolites, antineoplastic - adverse effects (259) 259
radiotherapy (259) 259
taxoids - administration & dosage (255) 255
survival analysis (250) 250
time factors (249) 249
carcinoma, squamous cell - drug therapy (247) 247
neoadjuvant therapy (247) 247
paclitaxel - administration & dosage (246) 246
adenocarcinoma - surgery (245) 245
survival (245) 245
drug therapy, combination (243) 243
metastasis (241) 241
phase-ii (240) 240
pancreatic neoplasms - drug therapy (239) 239
breast neoplasms - drug therapy (237) 237
antineoplastic agents (233) 233
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2541) 2541
Japanese (2167) 2167
Russian (29) 29
Chinese (23) 23
German (12) 12
Spanish (7) 7
French (3) 3
Italian (3) 3
Korean (3) 3
Czech (2) 2
Dutch (2) 2
Danish (1) 1
Hungarian (1) 1
Norwegian (1) 1
Polish (1) 1
Portuguese (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2013, Volume 14, Issue 13, pp. 1278 - 1286
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2010, Volume 11, Issue 9, pp. 853 - 860
Summary Background Fluorouracil and folinic acid with either oxaliplatin (FOLFOX) or irinotecan (FOLFIRI) are widely used as first-line or second-line... 
Hematology, Oncology and Palliative Medicine | TRIAL | CAPECITABINE | 1ST-LINE TREATMENT | INFUSIONAL FLUOROURACIL/LEUCOVORIN | THERAPY | ONCOLOGY | 5-FLUOROURACIL/FOLINIC ACID | FLUOROPYRIMIDINES | OXALIPLATIN | III NONINFERIORITY | FAILURE | Prodrugs - administration & dosage | Leucovorin - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Organoplatinum Compounds - administration & dosage | Fluorouracil - administration & dosage | Leucovorin - adverse effects | Fluorouracil - adverse effects | Colorectal Neoplasms - drug therapy | Adult | Camptothecin - administration & dosage | Female | Camptothecin - analogs & derivatives | Colorectal Neoplasms - mortality | Camptothecin - adverse effects | Fluorouracil - analogs & derivatives | Tegafur - adverse effects | Kaplan-Meier Estimate | Oxonic Acid - administration & dosage | Adenocarcinoma - drug therapy | Oxonic Acid - adverse effects | Disease-Free Survival | Prodrugs - adverse effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Tegafur - administration & dosage | Aged | Drug Combinations | Adenocarcinoma - mortality | Medical colleges | Chemotherapy | Oncology, Experimental | Colorectal cancer | Leucovorin | Research | Metastasis | Cancer | Fluorouracil | Analysis | Index Medicus
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2008, Volume 9, Issue 3, pp. 215 - 221
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 07/2013, Volume 31, Issue 20, pp. 2600 - 2606
Purpose Prior studies have suggested that patients with stage II/III colon cancer receive similar benefit from intravenous (IV) fluoropyrimidine adjuvant... 
PLUS LEUCOVORIN | III CARCINOMA | ONCOLOGY | COLORECTAL-CANCER | INDEPENDENTLY CONTRIBUTE | OLDER | POOLED ANALYSIS | COMPREHENSIVE GERIATRIC ASSESSMENT | FLUOROURACIL | ELDERLY-PATIENTS | CHEMOTHERAPY | Colorectal Neoplasms - surgery | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prognosis | Age Factors | Capecitabine | Humans | Middle Aged | Colectomy - methods | Male | Clinical Trials, Phase III as Topic | Organoplatinum Compounds - administration & dosage | Pyridines - adverse effects | Fluorouracil - administration & dosage | Fluorouracil - adverse effects | Colorectal Neoplasms - drug therapy | Adult | Camptothecin - administration & dosage | Deoxycytidine - adverse effects | Female | Chemotherapy, Adjuvant | Camptothecin - analogs & derivatives | Databases, Factual | Colorectal Neoplasms - mortality | Camptothecin - adverse effects | Pyridines - administration & dosage | Fluorouracil - analogs & derivatives | Risk Assessment | Deoxycytidine - administration & dosage | Tegafur - adverse effects | Treatment Outcome | Randomized Controlled Trials as Topic | Disease-Free Survival | Survival Analysis | Tegafur - administration & dosage | Aged | Colorectal Neoplasms - pathology | Deoxycytidine - analogs & derivatives | Organoplatinum Compounds - adverse effects | Index Medicus | Original Reports | Gic5
Journal Article
Annals of Surgical Oncology, ISSN 1068-9265, 8/2013, Volume 20, Issue 8, pp. 2647 - 2654
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2014, Volume 50, Issue 13, pp. 2231 - 2240
Journal Article
Journal Article
Journal of Hepatology, ISSN 0168-8278, 2011, Volume 55, Issue 4, pp. 858 - 865
Background & Aims Sorafenib plus metronomic tegafur/uracil therapy can induce tumor stabilization in advanced hepatocellular carcinoma (HCC) patients. This... 
Gastroenterology and Hepatology | Tegafur/uracil | Metronomic chemotherapy | Sorafenib | Vascular response | DCE-MRI | SOLID TUMORS | ANGIOGENESIS | PROGRESSION-FREE SURVIVAL | TUMOR RESPONSE | PHASE-II | CANCER | RENAL-CELL CARCINOMA | THERAPY | CLINICAL-TRIALS | GASTROENTEROLOGY & HEPATOLOGY | Neovascularization, Pathologic - mortality | Niacinamide - analogs & derivatives | Predictive Value of Tests | Carcinoma, Hepatocellular - mortality | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Middle Aged | Magnetic Resonance Imaging - methods | Male | Phenylurea Compounds | Antineoplastic Agents - administration & dosage | Benzenesulfonates - administration & dosage | Liver Neoplasms - mortality | Antimetabolites, Antineoplastic - administration & dosage | Feasibility Studies | Neovascularization, Pathologic - pathology | Young Adult | Carcinoma, Hepatocellular - drug therapy | Uracil - administration & dosage | Aged, 80 and over | Adult | Female | Liver Neoplasms - pathology | Pyridines - administration & dosage | Liver Neoplasms - drug therapy | Contrast Media | Neovascularization, Pathologic - drug therapy | Carcinoma, Hepatocellular - pathology | Biomarkers | Tegafur - administration & dosage | Aged | Rare earth metals | Medical colleges | Medical research | Prognosis | Patient outcomes | Glycoproteins | Hepatoma | Antineoplastic agents | Antimitotic agents | Liver cancer | Chemotherapy | Pyrimidines | Magnetic resonance imaging | Medicine, Experimental | Cancer | Index Medicus
Journal Article
Journal Article
Gastric Cancer, ISSN 1436-3291, 7/2016, Volume 19, Issue 3, pp. 902 - 910
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2014, Volume 89, Issue 3, pp. 547 - 555
Purpose To assess the long-term outcomes of patients with rectal cancer who received neoadjuvant chemoradiation therapy (NCRT) with concurrent S-1 and... 
Radiology | Hematology, Oncology and Palliative Medicine | PHASE-III TRIAL | CAPECITABINE | PLUS LEUCOVORIN | 5-FLUOROURACIL | ONCOLOGY | PREOPERATIVE RADIATION-THERAPY | CHEMORADIOTHERAPY | PROTRACTED VENOUS INFUSION | RADIOTHERAPY | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | CHEMOTHERAPY | FREE-RADICALS | Leucovorin - administration & dosage | Chemoradiotherapy - adverse effects | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Organoplatinum Compounds - administration & dosage | Fluorouracil - administration & dosage | Aged, 80 and over | Adult | Camptothecin - administration & dosage | Dose Fractionation | Female | Rectal Neoplasms - pathology | Agranulocytosis - etiology | Camptothecin - analogs & derivatives | Camptothecin - adverse effects | Chemoradiotherapy - methods | Drug Administration Schedule | Tegafur - adverse effects | Treatment Outcome | Oxonic Acid - administration & dosage | Rectal Neoplasms - therapy | Oxonic Acid - adverse effects | Rectal Neoplasms - mortality | Disease-Free Survival | Analysis of Variance | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Neoadjuvant Therapy - adverse effects | Neoadjuvant Therapy - methods | Tegafur - administration & dosage | Diarrhea - etiology | Aged | Leukopenia - etiology | Neoplasm Staging | Drug Combinations | Prognosis | Patient outcomes | Colorectal cancer | Adjuvant treatment | Cancer | Index Medicus | SURGERY | MULTIVARIATE ANALYSIS | PATIENTS | NEOPLASMS | RECTUM | LUNGS | RADIOLOGY AND NUCLEAR MEDICINE
Journal Article
Anticancer Research, ISSN 0250-7005, 05/2019, Volume 39, Issue 5, pp. 2483 - 2491
It remains unclear which chemotherapeutic regimens are better for the addition of bevacizumab. We conducted an exploratory randomized phase II trial comparing... 
CDDP | Phase 2 | Thymidylate synthase | Pemetrexed |